Bristol Myers Squibb reported a Phase 3 success and a pipeline cut as part of its second-quarter earnings Friday morning.
The company said a pivotal …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
–Recently announced positive Phase 1 topline safety, pharmacokinetic (“PK”) and pharmacodynamic (“PD”) data show that intravenous (“IV”) CYB004 demonstrated robust and rapid-onset psychedelic effects at
There was a “striking increase” in the number of cases of fetal situs inversus at two Chinese obstetric centers after the zero-COVID policies were lifted
EQS-News: Biotest AG / Key word(s): Half Year Results/Half Year Results Biotest increases sales in the first half of 2024 by 35% to Euro 372